Colonoscopy Techniques for Inflammatory Bowel Disease
Trial Summary
What is the purpose of this trial?
Inflammatory Bowel Disease (IBD) involving the colon is a known risk for colon cancer. There are two standards-of-care colonoscopy techniques used for screening all patients who suffer from IBD for more than eight years. One method is to obtain random biopsies throughout the colon and the other is by using dye spraying chromo-colonoscopy. This trial aims to study the difference between the two colonoscopy techniques during the era of high definition camera in detecting neoplastic lesions during screening patients with long-standing IBD.
Research Team
Eligibility Criteria
This trial is for adults over 18 with a history of Ulcerative Colitis, Crohn's disease affecting the colon, or unclassified colitis lasting at least eight years, or any duration if also diagnosed with primary sclerosing cholangitis. Participants must have significant colon involvement and not had a total colectomy or recent colonoscopy.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Dye Spraying Chromocolonoscopy (Procedure)
- High Definition Colonoscopy (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor
Dr. Kevin Tabb
Beth Israel Deaconess Medical Center
Chief Executive Officer since 2021
MD from Hebrew University Hadassah Medical School
Dr. Chi Chang Daniel Siao
Beth Israel Deaconess Medical Center
Chief Medical Officer since 2023
MD from King George’s Medical University